Nalgesin (Naproxen Sodium)

Naproxen sodium works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. This blockade reduces the formation of prostaglandins, which are chemical mediators responsible for pain, inflammation, and fever, thereby providing symptomatic relief.

The appropriate dose of Nalgesin is determined by a qualified prescriber based on the individual’s medical condition, age, weight, and response to therapy. Patients should follow the dosing instructions provided by their healthcare professional.

Safety of naproxen sodium in pregnancy or while breastfeeding has not been definitively established. Healthcare providers usually advise caution, especially in the third trimester, and may recommend alternative therapies when appropriate.

To place an order, submit an enquiry on the Nalgesin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both nalgesin (naproxen sodium) and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a slightly faster onset. Choice depends on clinical judgment, patient tolerance and specific therapeutic goals.

Nalgesin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Nalgesin is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it.

The most serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, and significant renal or hepatic impairment. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, unexplained bruising, or skin rash.

Nalgesin should be avoided by individuals with a known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, or uncontrolled hypertension. It is also contraindicated in patients who have experienced recent cardiovascular events or severe renal impairment.